Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study
A Ruffatti, T Del Ross, M Ciprian, MT Bertero… - Annals of the …, 2011 - ard.bmj.com
Objectives To assess risk factors for a first thrombotic event in confirmed antiphospholipid
(aPL) antibody carriers and to evaluate the efficacy of prophylactic treatments. Methods …
(aPL) antibody carriers and to evaluate the efficacy of prophylactic treatments. Methods …
Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study
A Ruffatti, T Del Ross, M Ciprian, M Nuzzo… - Annals of the …, 2009 - ard.bmj.com
Objectives: To asses risk factors for a first thrombotic event in antiphospholipid antibody
(aPL) positive carriers and evaluate the efficacy of prophylactic treatments. Methods …
(aPL) positive carriers and evaluate the efficacy of prophylactic treatments. Methods …
Primary thrombosis prophylaxis in antiphospholipid antibody–positive patients: where do we stand?
M Barbhaiya, D Erkan - Current rheumatology reports, 2011 - Springer
Persistently positive antiphospholipid antibodies (aPLs) with thrombosis and/or pregnancy
morbidity are the hallmark of the antiphospholipid syndrome. However, aPL-positive patients …
morbidity are the hallmark of the antiphospholipid syndrome. However, aPL-positive patients …
A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies
G Ruiz‐Irastorza, BJ Hunt… - Arthritis Care & …, 2007 - Wiley Online Library
Objective To systematically review the efficacy and safety data of different therapeutic
approaches in patients with antiphospholipid antibodies (aPL) and thrombosis. Methods The …
approaches in patients with antiphospholipid antibodies (aPL) and thrombosis. Methods The …
A cross‐sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome
D Erkan, Y Yazici, MG Peterson, L Sammaritano… - …, 2002 - academic.oup.com
Objective. Antiphospholipid antibodies (aPL) are major risk factors for thrombosis. Other
clinical factors exist in antiphospholipid syndrome (APS) patients which may have an …
clinical factors exist in antiphospholipid syndrome (APS) patients which may have an …
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
V Pengo, A Ruffatti, C Legnani, S Testa… - Blood, The Journal …, 2011 - ashpublications.org
Persistent antiphospholipid (aPL) antibodies are occasionally found in subjects without prior
history of thromboembolic events (TEs), raising the dilemma of whether to initiate or not a …
history of thromboembolic events (TEs), raising the dilemma of whether to initiate or not a …
Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies
MG Tektonidou, K Laskari… - Arthritis Care & …, 2009 - Wiley Online Library
Objective Antiphospholipid antibodies (aPL), namely anticardiolipin antibodies (aCL) and
lupus anticoagulant (LAC), have been associated with an increased risk of thrombosis in …
lupus anticoagulant (LAC), have been associated with an increased risk of thrombosis in …
Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
JA Girón-González, EG del Río, C Rodríguez… - The Journal of …, 2004 - jrheum.org
OBJECTIVE: We carried out a prospective analysis of clinical and analytical findings in
individuals with antiphospholipid antibodies (aPL). METHODS: We prospectively studied …
individuals with antiphospholipid antibodies (aPL). METHODS: We prospectively studied …
Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or …
CM Yelnik, G Urbanski, E Drumez, V Sobanski… - Lupus, 2017 - journals.sagepub.com
Introduction The long-term risk of first thrombosis and benefit of prophylaxis in
antiphospholipid antibody (aPL) carriers without history of thrombosis or obstetrical …
antiphospholipid antibody (aPL) carriers without history of thrombosis or obstetrical …
Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study
P Mustonen, KV Lehtonen, K Javela, M Puurunen - Lupus, 2014 - journals.sagepub.com
Objectives The long-term prognosis of individuals fulfilling the laboratory criteria, but not
clinical criteria, of antiphospholipid syndrome (APS) has not been widely investigated. The …
clinical criteria, of antiphospholipid syndrome (APS) has not been widely investigated. The …
相关搜索
- risk factors antibody carriers
- risk factors for thrombosis
- antibody positivity risk factor
- risk factors antiphospholipid syndrome
- risk factors preventive treatments
- risk factors lupus erythematosus
- obstetrical morbidity risk factor
- patients with antiphospholipid antibodies
- strong risk factor
- prospective analysis antiphospholipid antibody
- antiphospholipid antibodies secondary thromboprophylaxis
- antiphospholipid antibodies efficacy of aspirin
- antiphospholipid antibodies meta analysis
- antiphospholipid antibody profile
- antiphospholipid antibodies primary prevention
- antibody positivity history of thrombosis